Annual SG&A
$53.73 M
-$1.47 M-2.66%
31 December 2023
Summary:
Centessa Pharmaceuticals annual selling, general & administrative expenses is currently $53.73 million, with the most recent change of -$1.47 million (-2.66%) on 31 December 2023. During the last 3 years, it has risen by +$52.59 million (+4617.38%). CNTA annual SG&A is now -2.66% below its all-time high of $55.20 million, reached on 31 December 2022.CNTA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$12.50 M
+$1.34 M+11.97%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly selling, general & administrative expenses is currently $12.50 million, with the most recent change of +$1.34 million (+11.97%) on 30 September 2024. Over the past year, it has increased by +$483.00 thousand (+4.02%). CNTA quarterly SG&A is now -24.28% below its all-time high of $16.51 million, reached on 31 March 2021.CNTA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$3.26 B
-$161.26 M-5.21%
30 September 2024
Summary:
Centessa Pharmaceuticals TTM selling, general & administrative expenses is currently -$3.26 billion, with the most recent change of -$161.26 million (-5.21%) on 30 September 2024. Over the past year, it has dropped by -$3.31 billion (-6000.47%). CNTA TTM SG&A is now -1238.46% below its all-time high of $56.87 million, reached on 31 March 2023.CNTA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.7% | +4.0% | -6000.5% |
| 3 y3 years | +4617.4% | +0.3% | -5832.7% |
| 5 y5 years | - | - | - |
CNTA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2.7% | +4617.4% | -22.1% | +12.0% | -281.8% | at low |
| 5 y | 5 years | -2.7% | +6701.4% | -24.3% | +12.0% | -1238.5% | at low |
| alltime | all time | -2.7% | +6701.4% | -24.3% | +12.0% | -1238.5% | at low |
Centessa Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $12.50 M(+12.0%) | $49.42 M(+1.0%) |
| June 2024 | - | $11.16 M(-16.9%) | $48.94 M(-4.3%) |
| Mar 2024 | - | $13.44 M(+9.1%) | $51.12 M(-4.9%) |
| Dec 2023 | $53.73 M(-2.7%) | $12.31 M(+2.5%) | $53.73 M(-2.6%) |
| Sept 2023 | - | $12.02 M(-9.9%) | $55.18 M(-0.5%) |
| June 2023 | - | $13.35 M(-16.9%) | $55.45 M(-2.5%) |
| Mar 2023 | - | $16.05 M(+16.6%) | $56.87 M(+3.0%) |
| Dec 2022 | $55.20 M | $13.77 M(+12.1%) | $55.20 M(+33.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $12.28 M(-16.8%) | $41.43 M(-0.4%) |
| June 2022 | - | $14.76 M(+2.6%) | $41.61 M(+7.6%) |
| Mar 2022 | - | $14.38 M(+15.4%) | $38.69 M(-31.9%) |
| Sept 2021 | - | $12.46 M(+5.3%) | $56.80 M(+28.1%) |
| June 2021 | - | $11.84 M(-28.3%) | $44.34 M(+36.4%) |
| Mar 2021 | - | $16.51 M(+3.3%) | $32.49 M(+103.3%) |
| Dec 2020 | $1.14 M(+44.2%) | - | - |
| Dec 2020 | - | $15.98 M | $15.98 M |
| Dec 2019 | $790.00 K | - | - |
FAQ
- What is Centessa Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual SG&A year-on-year change?
- What is Centessa Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly SG&A year-on-year change?
- What is Centessa Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals TTM SG&A year-on-year change?
What is Centessa Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of CNTA is $53.73 M
What is the all time high annual SG&A for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual selling, general & administrative expenses is $55.20 M
What is Centessa Pharmaceuticals annual SG&A year-on-year change?
Over the past year, CNTA annual selling, general & administrative expenses has changed by -$1.47 M (-2.66%)
What is Centessa Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of CNTA is $12.50 M
What is the all time high quarterly SG&A for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $16.51 M
What is Centessa Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, CNTA quarterly selling, general & administrative expenses has changed by +$483.00 K (+4.02%)
What is Centessa Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of CNTA is -$3.26 B
What is the all time high TTM SG&A for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high TTM selling, general & administrative expenses is $56.87 M
What is Centessa Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, CNTA TTM selling, general & administrative expenses has changed by -$3.31 B (-6000.47%)